100 pharma deals of this magnitude still leaves it in the small to mid cap end of town.
Don't be fooled by the bio dollar headline. The timelines to get them versus the probability of success says its nothing more than wishful thinking.
These phylomers are nothing more than the next big thing congame. Just like the rest of biotech.
astrazeneca is the pharma , page-9
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $886.5M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 18.5¢ | $142.7K | 751.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 204334 | 18.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 345272 | 11 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| PYC (ASX) Chart |